Timber Pharmaceuticals to be Acquired by LEO Pharma
Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value Rights
To...
Press Release
Visiox Pharma Appoints Richard J. Rubino to Board of Directors
Thu August 17, 2023 | 09:28 pm
Visiox Pharma Appoints Richard J. Rubino to Board of Directors
Mr. Rubino brings extensive financial expertise to the Board
Served as Medco's CFO in $29 Billion acquisition by Express Scripts
...
PaxMedica Announces Positive Top Line Results from the PAX-101 (intravenous suramin) Phase 3 African Sleeping Sickness Study, PAX-HAT-301
Mon July 24, 2023 | 09:22 pm
PaxMedica Announces Positive Top Line Results from the PAX-101 (intravenous suramin) Phase 3 African Sleeping Sickness Study, PAX-HAT-301
PaxMedica Announces Positive Top Line Results from the PAX-101 (intravenous suramin) Phase 3 African Sleeping Sickness Study, PAX-HAT-3...
Visiox Pharma Licenses OMLONTI®
Wed July 19, 2023 | 09:21 pm
Visiox Pharma Licenses OMLONTI®
TARRYTOWN, N.Y., July 19, 2023 /PRNewswire/ -- Visiox Pharma, Inc., a privately funded biopharmaceutical company focused on the develop...
PaxMedica Grants Exclusive Pharmacy Distribution Rights
Thu July 6, 2023 | 09:19 pm
PaxMedica Grants Exclusive Pharmacy Distribution Rights
Exclusive pharmacy distribution agreement for PaxMedica’s lead pipeline asset, PAX-101, granted to Vox Nova LLC
TARRYTOWN, NY an...
Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
Tue June 20, 2023 | 09:15 pm
Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
- First presentation of data from Phase 3 ASCEND study will feature pharmacokinetic results that indicate minimal syste...
PaxMedica Rings the NASDAQ Closing Bell
Tue April 25, 2023 | 09:08 pm
PaxMedica Rings the NASDAQ Closing Bell
PaxMedica Celebrates Autism Awareness Month
On April 19, the PaxMedica team gathered to ring the closing bell on the NASDAQ exch...
PaxMedica Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering and Autism Awareness Month
Wed April 19, 2023 | 08:33 am
PaxMedica Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering and Autism Awareness Month
TARRYTOWN, NY, April 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceut...
PaxMedica, Inc. Secures $3.2 Million Growth Capital From Lind Partners
Fri February 3, 2023 | 08:00 am
PaxMedica, Inc. Secures $3.2 Million Growth Capital From Lind Partners
TARRYTOWN, NY, Feb. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceuti...
Visiox Pharma Announces FDA Acceptance of New Drug Application for Glaucoma
Thu December 8, 2022 | 07:58 pm
Visiox Pharma Announces FDA Acceptance of New Drug Application for Glaucoma
TARRYTOWN, N.Y., Dec. 8, 2022 /PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the developm...